The ins and outs of T-lymphocyte trafficking to the CNS: Anatomical sites and molecular mechanisms

Trends in Immunology

Volumn 26, Issue 9, 2005, Pages 485-495

  Engelhardt, Britta ^a   Ransohoff, Richard M ^b  

^a UNIVERSITY OF BERN   (Switzerland)

^b LERNER RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL ADHESION MOLECULE; CHEMOTACTIC FACTOR; NATALIZUMAB;

BLOOD BRAIN BARRIER; BRAIN REGION; CELL ADHESION; CELL INTERACTION; CENTRAL NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM DISEASE; CEREBROSPINAL FLUID; CHOROID PLEXUS; CIRCULATION; CLINICAL TRIAL; DISEASE MODEL; ENDOTHELIUM; EXTRAVASATION; HUMAN; IMMUNOPATHOGENESIS; IMMUNOSURVEILLANCE; INFLAMMATION; LEUKOCYTE MIGRATION; LEUKOCYTE ROLLING; MICROVASCULATURE; MOLECULAR MECHANICS; MULTIPLE SCLEROSIS; NERVOUS SYSTEM INFLAMMATION; NEUROANATOMY; NONHUMAN; PARENCHYMA; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RETINA; REVIEW; SIGNAL TRANSDUCTION; SPINAL CORD; T LYMPHOCYTE;

ANIMALS; CENTRAL NERVOUS SYSTEM; HUMANS; MODELS, IMMUNOLOGICAL; T-LYMPHOCYTES;

EID: 23744475685     PISSN: 14714906     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.it.2005.07.004     Document Type: Review

References (99)

1. P.B. Medawar Immunity to homologous grafted skin. III. The fate of skin homografts transplanted to the brain, to subcutaneous tissue and to anterior chamber of the eye Br. J. Exp. Pathol. 29 1948 58 69
2. A.H. Cross, and C.S. Raine Central nervous system endothelial cell-polymorphonuclear cell interactions during autoimmune demyelination Am. J. Pathol. 139 1991 1401 1409
3. E.H. Tran IFN-γ shapes immune invasion of the central nervous system via regulation of chemokines J. Immunol. 164 2000 2759 2768
4. A.R. Oliver Rat and human myelin oligodendrocyte glycoproteins induce experimental autoimmune encephalomyelitis by different mechanisms in C57BL/6 mice J. Immunol. 171 2003 462 468
5. U. Kniesel, and H. Wolburg Tight junctions of the blood-brain barrier Cell. Mol. Neurobiol. 20 2000 57 76
6. G. Allt, and J.G. Lawrenson Is the pial microvessel a good model for blood-brain barrier studies? Brain Res. Brain Res. Rev. 24 1997 67 76
7. F.J. Barkalow Brain endothelium lack one of two pathways of P-selectin-mediated neutrophil adhesion Blood 88 1996 4585 4593
8. T. Yong Nicotine induces leukocyte rolling and adhesion in the cerebral microcirculation of the mouse J. Neuroimmunol. 80 1997 158 164
9. L.A. Betz Blood-brain-cerebrospinal fluid barriers G.J. Siegel Basic Neurochemistry: Molecular, Cellular, and Medical Aspects 4th edn 1989 Raven Press 591 606
10. W.F. Hickey Migration of hematogenous cells through the blood-brain barrier and the initiation of CNS inflammation Brain Pathol. 1 1991 97 105
11. H. Wekerle Cellular immune reactivity within the CNS Trends Neurosci. 9 1986 271 277
12. 14C-labeled cells during acute, chronic, and relapsing experimental allergic encephalomyelitis Lab. Invest. 63 1990 162 170
13. W.F. Hickey Leukocyte traffic in the central nervous system: the participants and their roles Semin. Immunol. 11 1999 125 137
14. M.D. Carrithers Differential adhesion molecule requirements for immune surveillance and inflammatory recruitment Brain 123 2000 1092 1101
15. L. Piccio Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: critical roles for P-selectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors J. Immunol. 168 2002 1940 1949
16. P. Vajkoczy α4-Integrin-VCAM-1 binding mediates G protein-independent capture of encephalitogenic T cell blasts to CNS white matter microvessels J. Clin. Invest. 108 2001 557 565
17. M. Laschinger Encephalitogenic T cells use LFA-1 during transendothelial migration but not during capture and adhesion in spinal cord microvessels in vivo Eur. J. Immunol. 32 2002 3598 3606
18. E.C. Butcher Lymphocyte trafficking and regional immunity Adv. Immunol. 72 1999 209 253
19. H. Xu Requirements for passage of T lymphocytes across non-inflamed retinal microvessels J. Neuroimmunol. 142 2003 47 57
20. B. Engelhardt E- and P-selectin are not involved in the recruitment of inflammatory cells across the blood-brain barrier in experimental autoimmune encephalomyelitis Blood 90 1997 4459 4472
21. B.J. Steffen ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro Am. J. Pathol. 148 1996 1819 1838
22. + T cells: evidence for trafficking through choroid plexus and meninges via P-selectin Proc. Natl. Acad. Sci. U. S. A. 100 2003 8389 8394
23. A. Hamann Role of α4-integrins in lymphocyte homing to mucosal tissues in vivo J. Immunol. 152 1994 3282 3293
24. B. Engelhardt The development of experimental autoimmune encephalomyelitis in the mouse requires α4-integrin but not α4β7-integrin J. Clin. Invest. 102 1998 2096 2105
25. J.J. Provencio Comparison of ventricular and lumbar cerebrospinal fluid T cells in non-inflammatory neurological disorder (NIND) patients J. Neuroimmunol. 163 2005 179 184
26. P.G. McMenamin Distribution and phenotype of dendritic cells and resident tissue macrophages in the dura mater, leptomeninges, and choroid plexus of the rat brain as demonstrated in wholemount preparations J. Comp. Neurol. 405 1999 553 562
27. R.O. Weller Lymphocyte targeting of the central nervous system: a review of afferent and efferent CNS-immune pathways Brain Pathol. 6 1996 275 288
28. + T cells that induce experimental allergic encephalomyelitis J. Neuroimmunol. 40 1992 57 70
29. B. Engelhardt Adhesion molecule phenotype of T lymphocytes in inflamed CNS J. Neuroimmunol. 84 1998 92 104
30. E.J. McMahon Epitope spreading initiates in the CNS in two mouse models of multiple sclerosis Nat. Med. 11 2005 335 339
31. M. Greter Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis Nat. Med. 11 2005 328 334
32. W.F. Hickey, and H. Kimura Perivascular microglial cells of the CNS are bone marrow-derived and present antigen in vivo Science 239 1988 290 292
33. A. Flugel Migratory activity and functional changes of green fluorescent effector cells before and during experimental autoimmune encephalomyelitis Immunity 14 2001 547 560
34. B. Engelhardt Lymphocytes infiltrating the CNS during inflammation display a distinctive phenotype and bind to VCAM-1 but not to MAdCAM-1 Int. Immunol. 7 1995 481 491
35. S. Kerfoot, and P. Kubes Overlapping roles of P-selectin and α4 integrin to recruit leukocytes to the central nervous system in experimental autoimmune encephalomyelitis J. Immunol. 169 2002 1000 1006
36. + T cells from patients with acute multiple sclerosis display selective increase of adhesiveness in brain venules: a critical role for P-selectin glycoprotein ligand-1 Blood 101 2003 4775 4782
37. H. Xu Recruitment of IFN-γ-producing (Th1-like) cells into the inflamed retina in vivo is preferentially regulated by P-selectin glycoprotein ligand 1:P/E-selectin interactions J. Immunol. 172 2004 3215 3224
38. J. Carvalho-Tavares A role for platelets and endothelial selectins in tumor necrosis factor-α-induced leukocyte recruitment in the brain microvasculature Circ. Res. 87 2000 1141 1148
39. Engelhardt, B. et al. PSGL-1 is not required for the development of experimental autoimmune encephalomyelitis in SJL and C57Bl6 mice. J. Immunol. (in press)
40. S. Brocke Antibodies to CD44 and integrin α4, but not L-selectin, prevent central nervous system inflammation and experimental encephalomyelitis by blocking secondary leukocyte recruitment Natl. Acad. Sci. U. S. A. 96 1999 6896 6901
41. I.S. Grewal CD62L is required on effector cells for local interactions in the CNS to cause myelin damage in experimental allergic encephalomyelitis Immunity 14 2001 291 302
42. C. Alt Functional expression of the lymphoid chemokines CCL19 (ELC) and CCL 21 (SLC) at the blood-brain barrier suggests their possible involvement in lymphocyte recruitment into the central nervous system during experimental autoimmune encephalomyelitis Eur. J. Immunol. 32 2002 2133 2144
43. S. Columba-Cabezas Lymphoid chemokines CCL19 and CCL21 are expressed in the central nervous system during experimental autoimmune encephalomyelitis: implications for the maintenance of chronic neuroinflammation Brain Pathol. 13 2003 38 51
44. P. Kivisakk Expression of CCR7 in multiple sclerosis: implications for CNS immunity Ann. Neurol. 55 2004 627 638
45. + T cell accumulation in the central nervous system during experimental autoimmune encephalomyelitis J. Immunol. 166 2001 7617 7624
46. S. Narumi Neutralization of IFN-inducible protein 10/CXCL10 exacerbates experimental autoimmune encephalomyelitis Eur. J. Immunol. 32 2002 1784 1791
47. R.S. Klein IFN-inducible protein 10/CXC chemokine ligand 10-independent induction of experimental autoimmune encephalomyelitis J. Immunol. 172 2004 550 559
48. A.V. Andjelkovic Visualization of chemokine binding sites on human brain microvessels J. Cell Biol. 145 1999 403 412
49. M.E. Fuentes Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1 J. Immunol. 155 1995 5769 5776
50. S-C. Chen Central nervous system inflammation and neurological disease in transgenic mice expressing the CC chemokine CCL21 in oligodendrocytes J. Immunol. 168 2002 1009 1017
51. K. Boztug Leukocyte infiltration, but not neurodegeneration, in the CNS of transgenic mice with astrocyte production of the CXC chemokine ligand 10 J. Immunol. 169 2002 1505 1515
52. C. Ploix A ligand for the chemokine receptor CCR7 can influence the homeostatic proliferation of CD4 T cells and progression of autoimmunity J. Immunol. 167 2001 6724 6730
53. B.J. Steffen Evidence for involvement of ICAM-1 and VCAM-1 in lymphocyte interaction with endothelium in experimental autoimmune encephalomyelitis in the central nervous system in the SJL/J mouse Am. J. Pathol. 145 1994 189 201
54. J.L. Baron Surface expression of α4 integrin by CD4 T cells is required for their entry into brain parenchyma J. Exp. Med. 177 1993 57 68
55. B. Cannella, and C.S. Raine The adhesion molecule and cytokine profile of multiple sclerosis lesions Ann. Neurol. 37 1995 424 435
56. J.W. Peterson VCAM-1-positive microglia target oligodendrocytes at the border of multiple sclerosis lesions J. Neuropathol. Exp. Neurol. 61 2002 539 546
57. J.K. O'Neill Expression of vascular addressins and ICAM-1 by endothelial cells in the spinal cord during chronic relapsing experimental allergic encephalomyelitis in the Biozzi AB/H mouse Immunology 72 1991 520 525
58. T.A. Yednock Prevention of experimental autoimmune encephalomyelitis by antibodies against α4b1 integrin Nature 356 1992 63 66
59. S.J. Kent A monoclonal antibody to α4 integrin suppresses and reverses active experimental allergic encephalomyelitis J. Neuroimmunol. 58 1995 1 10
60. M. Laschinger, and B. Engelhardt Interaction of α4-integrin with VCAM-1 is involved in adhesion of encephalitogenic T cell blasts to brain endothelium but not in their transendothelial migration in vitro J. Neuroimmunol. 102 2000 32 43
61. J.R. Kanwar β7 Integrins contribute to demyelinating disease of the central nervous system J. Neuroimmunol. 103 2000 146 152
62. J.R. Kanwar Prevention of a chronic progressive form of experimental autoimmune encephalomyelitis by an antibody against mucosal addressin cell adhesion molecule-1, given early in the course of disease progression Immunol. Cell Biol. 78 2000 641 645
63. D. Graesser The interrelationship of α4 integrin and matrix metalloproteinase-2 in the pathogenesis of experimental autoimmune encephalomyelitis Lab. Invest. 78 1998 1445 1458
64. L.J. van der Laan Beneficial effect of modified peptide inhibitor of α4 integrins on experimental allergic encephalomyelitis in Lewis rats J. Neurosci. Res. 67 2002 191 199
65. B. Cannella Anti-adhesion molecule therapy in experimental autoimmune encephalomyelitis J. Neuroimmunol. 46 1993 43 55
66. C.T. Welsh Augmentation of adoptively transferred experimental allergic encephalomyelitis by administration of a monoclonal antibody specific for LFA-1α J. Neuroimmunol. 43 1993 161 168
67. J.J. Archelos Inhibition of experimental autoimmune encephalomyelitis by an antibody to the intercellular adhesion molecule ICAM-1 Ann. Neurol. 34 1993 145 154
68. D.O. Willenborg ICAM-1-dependent pathway is not critically involved in the inflammatory process of autoimmune encephalomyelitis or in cytokine-induced inflammation of the central nervous system J. Neuroimmunol. 45 1993 147 154
69. T.M. Carlos, and J.M. Harlan Leukocyte-endothelial adhesion molecules Blood 84 1994 2068 2101
70. Y. Reiss T cell interaction with ICAM-1-deficient endothelium in vitro: essential role for ICAM-1 and ICAM-2 in transendothelial migration of T cells Eur. J. Immunol. 28 1998 3086 3099
71. P. Adamson Lymphocyte migration through brain endothelial cell monolayers involves signaling through endothelial ICAM-1 via a rho-dependent pathway J. Immunol. 162 1999 2964 2973
72. R. Lyck T cell interaction with ICAM-1/ICAM-2-double-deficient brain endothelium in vitro: the cytoplasmic tail of endothelial ICAM-1 is necessary for transendothelial migration of T cells Blood 102 2003 3675 3683
73. J. Greenwood Intracellular domain of brain endothelial intercellular adhesion molecule-1 is essential for T lymphocyte-mediated signaling and migration J. Immunol. 171 2003 2099 2108
74. R.A. Sobel Intercellular adhesion molecule-1 (ICAM-1) in cellular immune reactions in the human central nervous system Am. J. Pathol. 136 1990 1309 1316
75. L. Bo Distribution of immunoglobulin superfamily members ICAM-1, -2, -3, and the β2 integrin LFA-1 in multiple sclerosis lesions J. Neuropathol. Exp. Neurol. 55 1996 1060 1072
76. B. Engelhardt, and H. Wolburg Mini-review: Transendothelial migration of leukocytes: through the front door or around the side of the house? Eur. J. Immunol. 34 2004 2955 2963
77. C.V. Carman, and T.A. Springer A transmigratory cup in leukocyte diapedesis both through individual vascular endothelial cells and between them J. Cell Biol. 167 2004 377 388
78. D. Graesser Changes in vascular permeability and early onset of experimental autoimmune encephalomyelitis in PECAM-1 (CD31) deficient mice J. Clin. Invest. 109 2002 383 392
79. K. Ebnet Junctional adhesion molecules (JAMs): more molecules with dual functions? J. Cell Sci. 117 2004 19 29
80. A. Del Maschio Leukocyte recruitment in the cerebrospinal fluid of mice with experimental meningitis is inhibited by an antibody to junctional adhesion molecule (JAM) J. Exp. Med. 190 1999 1351 1356
81. F. Lechner Antibodies to the junctional adhesion molecule cause disruption of endothelial cells and do not prevent leukocyte influx into the meninges after viral or bacterial infection J. Infect. Dis. 182 2000 978 982
82. A.R. Schenkel CD99 plays a major role in the migration of monocytes through endothelial junctions Nat. Immunol. 3 2002 143 150
83. G. Bixel Mouse CD99 participates in T-cell recruitment into inflamed skin Blood 104 2004 3205 3213
84. V.G. Sasseville Elevated vascular cell adhesion molecule-1 in AIDS encephalitis induced by simian immunodeficiency virus Am. J. Pathol. 141 1992 1021 1030
85. M. Deckert Schluter Differential expression of ICAM-1, VCAM-1 and their ligands LFA-1, Mac-1, CD43, VLA-4, and MHC class II antigens in murine Toxoplasma encephalitis: a light microscopic and ultrastructural immunohistochemical study J. Neuropathol. Exp. Neurol. 53 1994 457 468
86. K. Wolburg Ultrastructural localization of adhesion molecules in the healthy and inflamed choroid plexus of the mouse Cell Tissue Res. 296 1999 259 269
87. B. Serafini Intracerebral recruitment and maturation of dendritic cells in the onset and progression of experimental autoimmune encephalomyelitis Am. J. Pathol. 157 2000 1991 2002
88. B. Engelhardt Involvement of the choroid plexus in central nervous system inflammation Microsc. Res. Tech. 52 2001 112 129
89. B. Serafini Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis Brain Pathol. 14 2004 164 174
90. A. Corcione Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis Proc. Natl. Acad. Sci. U. S. A. 101 2004 11064 11069
91. D.H. Miller A controlled trial of natalizumab for relapsing multiple sclerosis N. Engl. J. Med. 348 2003 15 23
92. E.C. Butcher Leukocyte-endothelial cell recognition: three (or more) steps to specificity and diversity Cell 67 1991 1033 1036
93. E.C. Butcher Lymphocyte trafficking and regional immunity Adv. Immunol. 72 1999 209 253
94. T.A. Springer Traffic signals for lymphocyte recirculation and leukocyte emigration: the multistep paradigm Cell 76 1994 301 314
95. B.K. Kleinschmidt-Demasters, and K.L. Tyler Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon β1a for multiple sclerosis N. Engl. J. Med 2005 10.1056/NEJMoa051782 (http://content.nejm.org/)
96. A. Langer-Gould Progressive multifocal leukoencephalopathy in a patient treated with natalizumab N. Engl. J. Med 2005 10.1056/NEJMoa051847 (http://content.nejm.org/ )
97. G. Van Assche Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease N. Engl. J. Med 2005 10.1056/NEJMoa051586 (http://content.nejm.org/)
98. J.M. Drazen Patients at risk N. Engl. J. Med 2005 10.1056/NEJMe058123 (http://content.nejm.org/)
99. J.R. Berger, and I.J. Koralnik Progressive multifocal leukoencephalopathy and natalizumab - unforeseen consequences N. Engl. J. Med 2005 10.1056/NEJMe058122 (http://content.nejm.org/)